Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologic warfare for a good cause: HSV-1 anti-tumor therapy.

Clinical neurosurgery - 1 Jan 2004

Markert James M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease Vectors
Share to Gene Transfer Techniques
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Herpesvirus 1, Human

Share to Neoplasm Transplantation

Share to Viruses

Source

Identifiers

PMID: 15571130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologic warfare for a good cause: HSV-1 anti-tumor therapy.PMID 15571130Read ↗

Rethinking herpes simplex virus: the way to oncolytic agentsSemantic proximity Read ↗

Designing herpes viruses as oncolyticsSemantic proximity Read ↗

Oncolytic viral therapies – the clinical experienceSemantic proximity Read ↗

Active immunotherapy: oncolytic virus therapy using HSV-1.Semantic proximity Read ↗

Oncolytic herpes simplex virus vectors for cancer virotherapy.Semantic proximity Read ↗

Oncolytic virotherapy for cancer treatment: challenges and solutionsSemantic proximity Read ↗

The BMA report on biological and genetic weapons.Semantic proximity Read ↗

A novel oncolytic HSV-1 vector for cancer immunotherapySemantic proximity Read ↗

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacySemantic proximity Read ↗

Our best weapons against cancer are not magic bulletsSemantic proximity Read ↗

The oncolytic virus ΔPK has multimodal anti-tumor activity.Semantic proximity Read ↗

Strategies for immune evasion by human tumor virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.